The National Heart, Lung, and Blood Institute (NHLBI) awarded a $269,922 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Steth X Microsystems Inc., a for-profit company in Atlanta, Georgia. The grant project aims to develop a smart, wearable contact microphone patch for extended and remote monitoring of lung functions, particularly for respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). The wearable patch will utilize a novel,...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,052,276 to Lasarrus Clinic And Research Center Inc. to develop a wearable multimodal sensor system for remote monitoring of patients with chronic obstructive pulmonary disease (COPD). The project aims to enhance adherence to remote monitoring and early symptom recognition, in order to reduce COPD readmissions and healthcare costs....
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award provides $305,000 to Sensvita Inc. to develop a non-invasive radiofrequency sensing technology for home-based monitoring of heart and lung function. The project aims to design improved antennas for ambulatory use, enhance signal processing techniques to mitigate interference, and validate the system's accuracy against clinical benchmarks. The anticipated outcome is a robust and...
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded Aquillius Corp a $863,328 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837). The funding supports the development of a wearable graphene respiratory sensor for early detection and continuous monitoring of asthma, particularly in children. The goal is to create a cost-effective, robust device capable of real-time measurement of pulmonary functions to improve...
This $374,378 federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program is funding the development of computational models and a wearable, noninvasive carbon dioxide (CO2) sensing device. The goal is to accurately translate transcutaneous CO2 measurements (ptCO2) into clinically relevant arterial CO2 levels (paCO2), a vital...
This National Institutes of Health (NIH) R21/R33 grant award in the amount of $734,360 aims to develop and validate an innovative, inexpensive multi-modal digital stethoscope capable of automated lung sound and respiratory rate analysis, with mobile phone interoperability to an electronic health (eHealth) platform for real-time lower respiratory infection (LRI) and antibiotic surveillance in low- and middle-income countries (LMICs). The grant, awarded under the NIH's Child Health and Human...
The National Science Foundation awarded Aural Analytics, Inc. a $256,000 Project Grant under the Engineering (47.041) federal grant program. The grant funded the company's "STTR PHASE I: REMOTE ASSESSMENT OF RESPIRATORY FUNCTION IN HOSPITAL PATIENTS BASED ON SPEECH ACOUSTICS (COVID-19)" project from June 15, 2021 to February 28, 2022. The project aimed to develop technology using speech acoustics to remotely assess respiratory function in hospital patients, which has applications for...
This $999,994 cooperative agreement from the National Science Foundation under the Technology, Innovation, and Partnerships program will support Deepconvo Inc.'s development of voice-based telehealth products and services for respiratory disease monitoring and screening. Deepconvo will further develop its chronic obstructive pulmonary disease early exacerbation warning system to more accurately measure lung function deterioration through voice and breath data captured on mobile phones. Key...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will evaluate the use of mobile devices to extract vital signs to monitor patients with asthma. The $459,127 award to M5 Enterprise, LLC (doing business as Emedical Sentry) aims to improve the detection and management of asthma attacks through remote patient monitoring. The goal is to enhance telehealth by incorporating video-based vital sign...
This SBIR Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Ironsides Medical Inc. to develop a novel AI-powered otoscope for improved diagnosis of ear infections. The project aims to enhance clinicians' ability to accurately visualize the eardrum and make more accurate diagnoses, reducing the over-prescription of antibiotics and associated risks of antibiotic resistance. The key technical objectives...